For example, a recent experimental study has shown that genetically engineered NK cells without the TGFBR2 receptor can break the immunosuppressive milieu conferred by the TGF-β signaling pathway in the brain, allowing them to eliminate the tumor-regenerating glioblastoma stem cells [288]. The gene discussed is TGFB1; the disease is neoplasm.